What's Going On With Oscar Health Stock On Wednesday?

Core Viewpoint - Oscar Health Inc. is experiencing a decline in stock price despite a year-to-date gain of approximately 15%, attributed to a recent partnership with Hy-Vee to launch a new employer health insurance plan [1][5]. Group 1: Company Developments - Oscar Health announced a partnership with Hy-Vee to introduce "Hy-Vee Health with Oscar," an employer health insurance plan aimed at covering 400,000 local employees in Des Moines, Iowa, starting November 1, 2025 [1]. - The new insurance plan is expected to save businesses 20% to 30% and employees between $500 to $1,000 annually [2]. - Oscar Health reported second-quarter revenue of approximately $2.86 billion, an increase from $2.2 billion year-over-year, but fell short of the consensus estimate of $2.91 billion [3]. Group 2: Financial Performance - The company reported a loss of 89 cents per share for the second quarter, missing the consensus estimate of 86 cents [3]. - The medical loss ratio for the second quarter of 2025 was 91.1%, up from 79.0% in the same quarter of 2024, primarily due to increased market morbidity [4]. - Oscar Health reaffirmed its fiscal 2025 sales guidance of $12 billion to $12.2 billion, exceeding Wall Street's estimate of $11.32 billion, and expects a medical loss ratio of 86% to 87% for 2025 [4]. Group 3: Market Sentiment - The health insurance sector received a positive sentiment boost following investments from notable investors like Michael Burry and Warren Buffett in UnitedHealth Group, benefiting peers such as Oscar Health [5].